Literature DB >> 10379488

Crohn's disease: the case for bacteria.

C Prantera1, M L Scribano.   

Abstract

At the present time, there is no convincing indication that Crohn's disease is a bacterial disease, although an association with mycobacteria has been hypothesised for many years. The hypothesis that bacteria could be the cause, or at least an important concause of Crohn's disease is supported by several experimental and clinical observations: animals kept in a germ-free environment fail to develop intestinal inflammation; bacteria are the cause of human and animal intestinal diseases similar to Crohn's disease; luminal content is necessary for causing gut lesions; and, moreover, antibiotics are successfully used in the treatment of Crohn's disease. Bradford Hill criteria recently used to assess a causal relationship for Helicobacter pylori and peptic ulcer can be applied for establishing or excluding a causality between mycobacteria and Crohn's disease. Of these criteria, only biological plausibility, coherence and analogy are satisfied. However, failure to identify a specific pathogen does not exclude a possible role for bacteria in causing Crohn's disease lesions and symptoms. Pathogenic or commensal enteric bacteria could overinfect the primary lesions, leading to chronic intestinal inflammation in genetically susceptible hosts. Another possibility is that components of the normal intestinal flora could acquire pathogenic characteristics.

Entities:  

Mesh:

Year:  1999        PMID: 10379488

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  7 in total

1.  Probiotics for Crohn's disease: what have we learned?

Authors:  C Prantera
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 2.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

3.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

Authors:  C Prantera; M L Scribano; G Falasco; A Andreoli; C Luzi
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

4.  Detection of species-specific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis.

Authors:  C J Streutker; C N Bernstein; V L Chan; R H Riddell; K Croitoru
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice.

Authors:  Edward Balish; Thomas Warner
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

6.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

7.  Typing of Mycobacterium avium subspecies paratuberculosis isolates from Newfoundland using fragment analysis.

Authors:  Milka P Podder; Susan E Banfield; Greg P Keefe; Hugh G Whitney; Kapil Tahlan
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.